A 65-Year-Old Male with Primary Central Nervous System Diffuse Large B-Cell Lymphoma on Nivolumab with Oral Mucositis and Targetoid Plaques

BACKGROUND/AIMS: The development of programmed cell death-1 (PD-1) inhibitors has greatly improved patient outcomes in the treatment of a variety of advanced malignancies. These novel immunotherapies are not without adverse effects, the most common of which are dermatologic. METHODS: We report our e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Severine, Rohani, Pooyan, Nazarian, Rosalynn M., Kroshinsky, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Clinico-Pathological Correlation in Dermatopathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803687/
https://www.ncbi.nlm.nih.gov/pubmed/29456996
http://dx.doi.org/10.1159/000481309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803687/
https://www.ncbi.nlm.nih.gov/pubmed/29456996
http://dx.doi.org/10.1159/000481309

Ejemplares similares